Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients
暂无分享,去创建一个
[1] U. Reichelt,et al. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. , 2011, The Journal of investigative dermatology.
[2] B. Naume,et al. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern , 2011, Breast Cancer Research and Treatment.
[3] U. Keilholz,et al. Expression of the stem cell marker nestin in peripheral blood of patients with melanoma , 2010, The British journal of dermatology.
[4] N. Tsubota,et al. Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer , 2009, Clinical Cancer Research.
[5] H. Taubert,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[6] J. Chalmers,et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells , 2009, Biotechnology and bioengineering.
[7] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[8] M. Kitajima,et al. Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers , 2008, Annals of Surgical Oncology.
[9] M. Tan,et al. The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method , 2008, Breast Cancer Research and Treatment.
[10] D. Krag,et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.
[11] Mehmet Toner,et al. Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.
[12] C. Prior,et al. Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION Techniques , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Moll,et al. The human keratins: biology and pathology , 2008, Histochemistry and Cell Biology.
[15] Ruud H. Brakenhoff,et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.
[16] T. Kroll,et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[18] Glenn Heller,et al. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.
[19] A. Look,et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. , 2007, Cancer research.
[20] R. Bast,et al. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. , 2007, Journal of oncology practice.
[21] P. Bunn,et al. Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma , 2007, Molecular Cancer Therapeutics.
[22] H. Ju,et al. Circulating Tumor Cells in Perioperative Esophageal Cancer Patients: Quantitative Assay System and Potential Clinical Utility , 2007, Clinical Cancer Research.
[23] E. Thiel,et al. Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma , 2007, Clinical Cancer Research.
[24] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[25] E. Thiel,et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Izbicki,et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. , 2005, Journal of the National Cancer Institute.
[27] G. Sauter,et al. Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells , 2005, Clinical Cancer Research.
[28] C. Rao,et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Falk Schubert,et al. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. , 2005, Journal of immunological methods.
[30] K. Pantel,et al. Influence of immunomagnetic enrichment on gene expression of tumor cells , 2005, Journal of Translational Medicine.
[31] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[32] Maciej Zborowski,et al. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. , 2004, Experimental hematology.
[33] D. Schadendorf,et al. Functional CCR9 expression is associated with small intestinal metastasis. , 2004, The Journal of investigative dermatology.
[34] E. Thiel,et al. Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction , 2004, Clinical Cancer Research.
[35] Heike Pohla,et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. , 2003, The Journal of urology.
[36] D. Pinkel,et al. High‐resolution genomic profiling of occult micrometastatic tumor cells , 2003, Genes, chromosomes & cancer.
[37] M. Wirth,et al. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. , 2002, International journal of oncology.
[38] A. Giuliano,et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. , 2001, Cancer research.
[39] M. Speicher,et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] U. Schumacher,et al. Epithelial Glycoprotein-2 Expression is Subject to Regulatory Processes in Epithelial–mesenchymal Transitions During Metastases: an Investigation of Human Cancers Transplanted into Severe Combined Immunodeficient Mice , 1998, The Histochemical Journal.
[41] U. Keilholz,et al. Stem cell marker nestin expression in peripheral blood of patients with melanoma. , 2010 .
[42] Alessandro Lugli,et al. Frequent EpCam protein expression in human carcinomas. , 2004, Human pathology.
[43] H. Taubert,et al. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. , 2004, Gynecologic oncology.